Mometasone furoate MDI (MF MDI)

DRUG4 trials

Sponsors

Organon and Co

Conditions

AsthmaChronic Obstructive Pulmonary Disease (COPD)

Phase 3

Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)

CompletedNCT00381485

Organon and CoAsthma

Start: 2006-07-01End: 2008-01-01Updated: 2024-05-20

Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)

CompletedNCT00383721

Organon and CoChronic Obstructive Pulmonary Disease (COPD)

Start: 2006-09-30End: 2010-07-31Updated: 2024-05-23

Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)

CompletedNCT00383552

Organon and CoAsthma

Start: 2006-09-30End: 2008-08-31Updated: 2024-05-17

Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)

CompletedNCT00383435

Organon and CoChronic Obstructive Pulmonary Disease (COPD)

Start: 2006-10-31End: 2010-07-31Updated: 2024-05-20

Related Papers

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.

2014-05-025 citations